» Articles » PMID: 30574051

TLR2/4-mediated NF-κB Pathway Combined with the Histone Modification Regulates β-defensins and Interleukins Expression by Sodium Phenyl Butyrate in Porcine Intestinal Epithelial Cells

Overview
Journal Food Nutr Res
Date 2018 Dec 22
PMID 30574051
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Host defense peptides (HDPs) possess direct antibacterial, antineoplastic, and immunomodulatory abilities, playing a vital role in innate immunity. Dietary-regulated HDP holds immense potential as a novel pathway for preventing infection.

Objective: In this study, we examined the regulation mechanism of HDPs (pEP2C, pBD-1, and pBD-3) and cytokines (IL-8 and IL-18) expression by sodium phenylbutyrate (PBA).

Design: The effects of PBA on HDP induction and the mechanism involved were studied in porcine intestinal epithelial cell lines (IPEC J2).

Results: In this study, the results showed that HDPs (pEP2C, pBD-1, and pBD-3) and cytokines (IL-8 and IL-18) expression was increased significantly upon stimulation with PBA in IPEC J2 cells. Furthermore, toll-like receptor 2 (TLR2) and TLR4 were required for the PBA-mediated upregulation of the HDPs. This process occurred and further activated the NF-κB pathway via the phosphorylation of p65 and an IκB α synthesis delay. Meanwhile, histone deacetylase (HDAC) inhibition and an increased phosphorylation of histone H3 on serine S10 also occurred in PBA-induced HDP expression independently with TLR2 and TLR4. Furthermore, p38-MAPK suppressed PBA-induced pEP2C, pBD-1 pBD-3, IL-8, and IL-18 expression, but ERK1/2 failed to abolish the regulation of pBD-3, IL-8, and IL-18. Moreover, epidermal growth factor receptor (EGFR) is involved in PBA-mediated HDP regulation.

Conclusions: We concluded that PBA induced HDP and cytokine increases but did not cause an excessive pro-inflammatory response, which proceeded through the TLR2 and TLR4-NF-κB pathway and histone modification in IPEC J2 cells.

Citing Articles

Porcine β-defensin 5 (pBD-5) modulates the inflammatory and metabolic host intestinal response to infection.

Finatto A, Yang C, de Oliveira Costa M Sci Rep. 2025; 15(1):7568.

PMID: 40038370 PMC: 11880483. DOI: 10.1038/s41598-025-90688-8.


Piggybacking on nature: exploring the multifaceted world of porcine β-defensins.

Finatto A, Meurens F, de Oliveira Costa M Vet Res. 2025; 56(1):47.

PMID: 40033445 PMC: 11877871. DOI: 10.1186/s13567-025-01465-4.


The intestinal clock drives the microbiome to maintain gastrointestinal homeostasis.

Heddes M, Altaha B, Niu Y, Reitmeier S, Kleigrewe K, Haller D Nat Commun. 2022; 13(1):6068.

PMID: 36241650 PMC: 9568547. DOI: 10.1038/s41467-022-33609-x.


Sheep β-Defensin 2 Regulates F17 Resistance via NF-κB and MAPK Signaling Pathways in Ovine Intestinal Epithelial Cells.

Ge L, Zou S, Yuan Z, Chen W, Wang S, Cao X Biology (Basel). 2021; 10(12).

PMID: 34943272 PMC: 8698448. DOI: 10.3390/biology10121356.


Histone Deacetylases in the Inflamed Intestinal Epithelium-Promises of New Therapeutic Strategies.

Gerbeth L, Glauben R Front Med (Lausanne). 2021; 8:655956.

PMID: 33842512 PMC: 8032862. DOI: 10.3389/fmed.2021.655956.

References
1.
Saccani S, Pantano S, Natoli G . p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment. Nat Immunol. 2001; 3(1):69-75. DOI: 10.1038/ni748. View

2.
Stadnyk A . Intestinal epithelial cells as a source of inflammatory cytokines and chemokines. Can J Gastroenterol. 2002; 16(4):241-6. DOI: 10.1155/2002/941087. View

3.
Clayton A, Mahadevan L . MAP kinase-mediated phosphoacetylation of histone H3 and inducible gene regulation. FEBS Lett. 2003; 546(1):51-8. DOI: 10.1016/s0014-5793(03)00451-4. View

4.
Hertz C, Wu Q, Porter E, Zhang Y, Weismuller K, Godowski P . Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2. J Immunol. 2003; 171(12):6820-6. DOI: 10.4049/jimmunol.171.12.6820. View

5.
Quivy V, Van Lint C . Regulation at multiple levels of NF-kappaB-mediated transactivation by protein acetylation. Biochem Pharmacol. 2004; 68(6):1221-9. DOI: 10.1016/j.bcp.2004.05.039. View